Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Destination therapy with ventricular assist devices.

Jai Raman1, Valluvan Jeevanadam

  • 1Section of Cardiothoracic Surgery, University of Chicago Medical Center, Chicago, IL 60637, USA. jraman@surgery.bsd.uchicago.edu

Cardiology
|February 28, 2004
PubMed
Summary

Mechanical assist devices show promise for heart failure patients, significantly improving survival rates compared to medical therapy alone. However, challenges like mechanical issues and infections persist with current ventricular assist devices (VADs).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of Sarcopenia using Chest Computed Tomography of the Pectoralis Major Muscle as a Prognostic Tool for Cardiac Surgery Outcomes.

Heart, lung & circulation·2026
Same author

A Multicentre Observational Study of Prothrombin Complex Concentrate Therapy in Cardiac Surgery Patients.

Heart, lung & circulation·2026
Same author

Renal Medullary but Not Cerebral Hypoxia in a Large Animal Model of Heart Failure With Mildly Reduced Ejection Fraction.

Comprehensive Physiology·2025
Same author

Arrhythmogenic mitral valve prolapse-a systematic review of ventricular arrhythmia and sudden cardiac death outcomes before and after mitral valve surgery.

Journal of arrhythmia·2025
Same author

Renal macro- and microcirculatory perturbations in acute kidney injury and chronic kidney disease associated with heart failure and cardiac surgery.

American journal of physiology. Renal physiology·2025
Same author

DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1<sup>+</sup> T-Lineage Cancers.

ACS applied materials & interfaces·2025

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering

Background:

  • Heart failure incidence is rising globally, with limited donor hearts for transplantation.
  • Permanent mechanical assist devices are crucial for managing advanced heart failure.
  • Current ventricular assist devices (VADs) face challenges including mechanical failure, bleeding, and infection.

Purpose of the Study:

  • To evaluate the efficacy of device therapy (HeartMate) versus maximal medical therapy in patients with congestive heart failure.
  • To compare survival rates between VADs and medical management in heart failure treatment.

Main Methods:

  • A randomized study comparing HeartMate device therapy against maximal medical therapy for heart failure.
  • Kaplan-Meier survival analysis was used to assess outcomes at one year.

Related Experiment Videos

Main Results:

  • The study demonstrated a significantly higher 1-year survival rate of 52% for the HeartMate device group compared to 25% for the medical therapy group.
  • The HeartMate device is approved for destination therapy, while other VADs are under evaluation.

Conclusions:

  • Ventricular assist devices (VADs) offer a survival benefit for heart failure patients over medical therapy.
  • Ongoing research focuses on improving VAD technology, including smaller impeller pumps and implantable balloon pumps, to overcome existing limitations.